# Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection

> **NCT05872659** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shandong Qilu Cell Therapy Engineering Technology Co., Ltd** · enrollment: 20 (estimated)

## Conditions studied

- AIDS Virus
- Disorder of Immune Reconstitution

## Interventions

- **OTHER:** normal saline
- **BIOLOGICAL:** Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT05872659
- **Lead sponsor:** Shandong Qilu Cell Therapy Engineering Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-16
- **Primary completion:** 2025-11-15
- **Final completion:** 2025-11-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05872659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05872659, "Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05872659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*